CCC
LLY icon

Chesapeake Capital Corp’s Eli Lilly LLY Stock Holding History

Chesapeake Capital Corp’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$347K Buy
289
+64
+28% +$65.4K 0.18% 149
2026
Q1 		$207K Buy
225
+24
+12% +$24.3K 0.15% 156
2025
Q4 		$216K Buy
+201
New +$192K 0.18% 153

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Chesapeake Capital Corp's LLY Position: Q2 2026 in Review

Chesapeake Capital Corp increased its Eli Lilly (LLY) stake by 28% in Q2 2026, buying an estimated $65.4K and bringing the position to 289 shares worth $347K. The position accounts for 0.18% of the portfolio, ranked #149.

Chesapeake Capital Corp first reported a position in LLY in Q4 2025 and has held it in 3 quarters since. 4,634 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Chesapeake Capital Corp held 289 shares of Eli Lilly worth $347K as of Q2 2026.
  • Chesapeake Capital Corp bought 64 Eli Lilly shares in Q2 2026, an estimated $65.4K.
  • Eli Lilly made up 0.18% of Chesapeake Capital Corp's portfolio in Q2 2026, its #149 holding.
  • Chesapeake Capital Corp first reported a position in Eli Lilly in Q4 2025 and has held it in 3 quarters since.
  • 4,634 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Chesapeake Capital Corp's 13F filing for Q2 2026, filed 29 Jul 2026.